EP1499303A4 - Multi-phase, multi-compartment capsular system - Google Patents

Multi-phase, multi-compartment capsular system

Info

Publication number
EP1499303A4
EP1499303A4 EP03717010A EP03717010A EP1499303A4 EP 1499303 A4 EP1499303 A4 EP 1499303A4 EP 03717010 A EP03717010 A EP 03717010A EP 03717010 A EP03717010 A EP 03717010A EP 1499303 A4 EP1499303 A4 EP 1499303A4
Authority
EP
European Patent Office
Prior art keywords
phase
capsular system
compartment capsular
compartment
capsular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03717010A
Other languages
German (de)
French (fr)
Other versions
EP1499303A2 (en
Inventor
Fred H Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/368,951 external-priority patent/US20030194428A1/en
Application filed by Individual filed Critical Individual
Publication of EP1499303A2 publication Critical patent/EP1499303A2/en
Publication of EP1499303A4 publication Critical patent/EP1499303A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C39/10—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles incorporating preformed parts or layers, e.g. casting around inserts or for coating articles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0058—Liquid or visquous
    • B29K2105/0061—Gel or sol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP03717010A 2002-04-10 2003-04-09 Multi-phase, multi-compartment capsular system Withdrawn EP1499303A4 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US368951 1989-06-13
US37144802P 2002-04-10 2002-04-10
US371448P 2002-04-10
US369247 2003-02-18
US369244 2003-02-18
US369427 2003-02-18
US10/368,951 US20030194428A1 (en) 2002-04-10 2003-02-18 Process for encapsulating multi-phase, multi-compartment capsules
US10/369,244 US20030194429A1 (en) 2002-04-10 2003-02-18 Multi-phase, multi-compartment capsular delivery apparatus for therapeutic compositions and methods for using same
US10/369,247 US20030194430A1 (en) 2002-04-10 2003-02-18 Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions
US10/369,427 US20030194431A1 (en) 2002-04-10 2003-02-18 Multi-phase,multi-compartment capsular delivery apparatus and methods for using same
PCT/US2003/010816 WO2003086267A2 (en) 2002-04-10 2003-04-09 Multi-phase, multi-compartment capsular system

Publications (2)

Publication Number Publication Date
EP1499303A2 EP1499303A2 (en) 2005-01-26
EP1499303A4 true EP1499303A4 (en) 2007-07-25

Family

ID=29255682

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03717010A Withdrawn EP1499303A4 (en) 2002-04-10 2003-04-09 Multi-phase, multi-compartment capsular system

Country Status (6)

Country Link
EP (1) EP1499303A4 (en)
JP (2) JP2005528383A (en)
AU (3) AU2003220689A1 (en)
CA (1) CA2481486C (en)
NZ (1) NZ536267A (en)
WO (1) WO2003086267A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108753621A (en) * 2018-05-30 2018-11-06 昆明理工大学 A method of based on molasses give up mash improve single needle algae oil and fat accumulation

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163693B1 (en) 1999-07-30 2007-01-16 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
US7790762B2 (en) 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
US20040087527A1 (en) 2002-10-31 2004-05-06 Day Brian J. Methods for treatment of thiol-containing compound deficient conditions
DE10359792A1 (en) * 2003-12-19 2005-07-21 Bayer Technology Services Gmbh Multiphasic drug formulation
CN1956733B (en) * 2004-04-07 2012-10-10 白藜芦醇合伙人有限责任公司 Dietary supplement and method of processing same
PL1836665T3 (en) 2004-11-19 2013-06-28 Glaxosmithkline Llc Method for customized dispensing of variable dose drug combination products for individualizing of therapies
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
JP2006321730A (en) * 2005-05-17 2006-11-30 Maruzen Pharmaceut Co Ltd Antioxidant, antiaging agent, skin cosmetics, and food or drink
US7781572B2 (en) 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
JP5869745B2 (en) 2006-02-03 2016-02-24 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー Treatment of vitamin D deficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
EP3659608A1 (en) 2006-06-21 2020-06-03 Opko Ireland Global Holdings, Ltd. Therapy using vitamin d repletion agent and vitamin d hormone replacement agent
PL2046334T3 (en) 2006-07-25 2015-02-27 Vecta Ltd Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
CN104257667B (en) 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 Treat vitamin d insufficiency and shortage, secondary hyperparathyroidism and vitamin D-responsive diseases method and composition
ES2956794T3 (en) 2007-04-25 2023-12-28 Eirgen Pharma Ltd Controlled release of 25-hydroxyvitamin D
CA2639895C (en) 2007-10-05 2014-06-10 David Rowland Energizing compositions comprising goji, red clover and polygonum multiflorum, and uses thereof
US20120145572A1 (en) * 2009-04-20 2012-06-14 Ecole Polytechnique Federale De Lausanne (Epfl) Containers assembled in fluid and corresponding production
KR101143997B1 (en) * 2010-03-04 2012-05-09 한미사이언스 주식회사 Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof
KR102125424B1 (en) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 Methods and compositions for reducing parathyroid levels
CA3065589C (en) 2010-06-03 2022-04-26 Catalent Ontario Limited Multi phase soft gel capsules, apparatus and method thereof
ES2651933T3 (en) * 2010-07-19 2018-01-30 Procaps S.A. Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
US20120082719A1 (en) * 2010-10-05 2012-04-05 Sam Poon Ang Compositions For Treating Chronic Viral Infections
CN102335095A (en) * 2011-10-12 2012-02-01 李思思 Manufacturing technology of d-limonene hard capsules
US10071199B2 (en) 2013-03-15 2018-09-11 Incube Labs, Llc Multi-stage biodegradable drug delivery platform
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
SG10201911274TA (en) 2014-08-07 2020-02-27 Opko Ireland Global Holdings Ltd Adjunctive therapy with 25-hydroxyvitamin d
US9980993B2 (en) 2014-11-06 2018-05-29 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
US9468659B2 (en) 2014-11-06 2016-10-18 NWO Stem Cure, LLC Nutraceutical supplement with Lactobacillus rhamnosus
BR112018069727A2 (en) 2016-03-28 2019-02-05 Opko Ireland Global Holdings Ltd vitamin d treatment methods
JP7229012B2 (en) 2018-12-25 2023-02-27 小林製薬株式会社 Pharmaceutical composition for internal use
IT201900025063A1 (en) * 2019-12-20 2021-06-20 Idi Integratori Dietetici Italiani S R L GASTRORESISTANT COMPOSITIONS INCLUDING INOSITOL AND / OR SYLVESTRE GYMNEMA EXTRACT, THEIR PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS AND THEIR USE
CN116648239A (en) * 2021-08-26 2023-08-25 宁德时代新能源科技股份有限公司 Liquid bag, battery monomer, battery and electricity utilization device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2729068A1 (en) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Releasing incompatible pharmaceuticals from capsules - by including a second capsule inside the first
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
WO2002007710A2 (en) * 2000-07-20 2002-01-31 Mw Encap Limited Delivery device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185740A (en) * 1978-08-02 1980-01-29 Johnson & Johnson Disposable capsules
CH661878A5 (en) * 1983-11-04 1987-08-31 Warner Lambert Co CAPSULE DOSING FORMS.
JPS6342094Y2 (en) * 1985-07-02 1988-11-04
DE3543154A1 (en) * 1985-12-06 1987-06-11 Boehringer Ingelheim Kg DIVISIBLE CAPSULE
US4940499A (en) * 1989-05-23 1990-07-10 Warner-Lambert Company Method and apparatus for sealing capsules containing medicaments
DE69013923T2 (en) * 1989-08-17 1995-03-16 Cortecs Ltd., Isleworth MEDICINAL FORMULATIONS.
JPH06316517A (en) * 1993-02-22 1994-11-15 Grelan Pharmaceut Co Ltd Sustained-release preparation
JP2000239159A (en) * 1999-02-19 2000-09-05 Nitto Yakuhin Kogyo Kk Capsule preparation and it production
ITMI20000788A1 (en) * 1999-04-13 2001-10-11 Beecham Pharmaceuticals Pte Li NEW METHOD OF TREATMENT
GB2358382B (en) * 1999-11-17 2003-01-29 Reckitt Benckiser Rigid water-soluble containers
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2729068A1 (en) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Releasing incompatible pharmaceuticals from capsules - by including a second capsule inside the first
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
WO2002007710A2 (en) * 2000-07-20 2002-01-31 Mw Encap Limited Delivery device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108753621A (en) * 2018-05-30 2018-11-06 昆明理工大学 A method of based on molasses give up mash improve single needle algae oil and fat accumulation

Also Published As

Publication number Publication date
CA2481486C (en) 2012-06-12
NZ536267A (en) 2007-06-29
AU2009202495B2 (en) 2011-02-10
AU2003220689A1 (en) 2003-10-27
JP2011068664A (en) 2011-04-07
WO2003086267A2 (en) 2003-10-23
JP2005528383A (en) 2005-09-22
AU2011202164A1 (en) 2011-06-02
AU2009202495A1 (en) 2009-07-16
WO2003086267B1 (en) 2004-04-29
WO2003086267A3 (en) 2003-12-18
EP1499303A2 (en) 2005-01-26
CA2481486A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
EP1499303A4 (en) Multi-phase, multi-compartment capsular system
AU2003272435A8 (en) Packaging system
GB0312365D0 (en) Novel 3-substituted-1, 4-benzodiazepines
GB0211419D0 (en) Dosing system
NZ527418A (en) Packaging system
AU2003292453A8 (en) Tamper-resisting packaging
AU2003304052A8 (en) Meso-microelectromechanical system package
GB2390844B (en) Packaging case
GB2386596B (en) Packaging
GB0312467D0 (en) Generator system
GB2396630B (en) Restraining means
GB0212883D0 (en) Packaging
GB2397057B (en) Packaging
GB2400357B (en) Restraining system
GB0223557D0 (en) Filling system
PL363296A1 (en) Packaging
GB2393712B (en) Packaging
ZA200305717B (en) Packaging arrangement.
PL358861A1 (en) System designed for packaging small, oval objects
GB0325330D0 (en) Packaging system
GB0209422D0 (en) Packaging system
ZA200304110B (en) Bag.
ZA200303720B (en) Containers.
ZA200210155B (en) Containers.
ZA200302985B (en) Securing means.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041109

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1074396

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20070625

17Q First examination report despatched

Effective date: 20100712

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1074396

Country of ref document: HK

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20141202